Abstract
Resistance (lowered susceptibility) to metronidazole and other 5-nitroimidazoles occurs, albeit infrequently, in clinical isolates of the normally susceptible anaerobic microorganisms, Trichomonas vaginalis and Bacteroides spp. Such resistance has been induced by in vivo drug pressure in T. vaginalis and Tritrichomonas foetus and by in vitro drug pressure in B. fragilis. All organisms studied showed cross-resistance to other 5-nitro-imidazoles expressed to a different degree. The detection of resistance depends on the assay method used. The mechanism of resistance in natural isolates and in strains of trichomonads developed in vivo is unknown but seems to be connected with aerobic conditions. Resistance of in vitro developed T. foetus strains and of all B. fragilis strains studied is related to a decreased activity of pyruvate:ferredoxin oxidoreductase, responsible for the metabolic activation of 5-nitroimidazoles.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J. G. Meingassner and J. Thurner, Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitro- imidazoles, Antimicrob. Agents Chemother. 15: 254 (1979).
J. G. Meingassner, L. Havelec, and H. Mieth, Studies on strain sensitivity of Trichomonas vaginalis to metronidazole, Brit. J. Vener. Pis. 54: 72 (1978).
M. Müller, J. G. Meingassner, W. A. Miller and W. J. Ledger, Three metronidazole-resistant strains of Trichomonas vaginalis from the USA, Am. J. Obst. Gyn. (in press).
F. Benazet and L. Guillaume, Induction of in vivo resistance of Trichomonas vaginalis to nitrimidazine, Lancet 2: 982 (1971).
J. Thurner and J. G. Meingassner, Isolation of Trichomonas vaginalis resistant to metronidazole, Lancet 2: 738 (1978).
A. Forsgren and L. Forssman, Metronidazole-resistant Trichomonas vaginalis, Brit. J. Vener. Dis. 55: 351 (1979).
J. G. Meingassner and H. Mieth, Cross-resistance of trichomonads to 5-nitroimidazole-derivatives, Experientia 23: 183 (1976).
A. Čerkasovovà, J. Cerkasov, J. Kulda and P.Demes, Metronidazole action on Tritrichomonas foetus: enzyme activities in the strains of a different resistance to the drug in: “The Host-Invader Interplay. Third International Symposium on the Physiology of Parasites and Host-Parasite Relationships”, H. van den Bossche, ed., Elsevier/North-Holland Biomedical Press, Amsterdam (1980).
M. L. Britz and R. G. Wilkinson, Isolation and properties of metronidazole-resistant mutants of Bacteroides fragilis, Antimicrob. Agents Chemother. 16: 19 (1979).
M. Mtiller, Mode of action of metronidazole on anaerobic microorganisms, in: “Metronidazole: Proceedings of the 2nd International Symposium on Anaerobic Infections, Series No.18”, I. Phillips and J. Collier, eds., The Royal Society of Medicine, London (1979).
B.M. Honigberg, Trichomonads of importance in human medicine, in: “Parasitic Protozoa, Vol.11”, J.P. Kreier, ed., Academic Press, New York (1978).
I. de Carneri, Perspectives in the treatment of protozoal diseases resistant to metronidazole, Trans. Roy. Soc. Trop. Med. Hyg. 65: 268 (1971).
I. de Carneri and F. Trane, In vivo resistance to metronidazole induced on four recently isolated strains of Trichomonas vaginalis, Drug Res. 21: 377 (1971).
P. Durel, J. Couture and M.T. Bassoullet, Commentaires sur deux cas de vaginite a T. vaginalis guéris avec difficulté par le métronidazole, Wiad. Parazytol. 12: 422 (1966).
P. Actor, D.S. Ziv and J. F. Pagano, Resistance to metronidazole by Tritrichomonas foetus in hamsters infected intravaginally, Science 164: 439 (1969).
E. Shelagh, E. Milne, J. Stokes and P.M. Waterworth, Incomplete anaerobiosis as a cause of metronidazole ‘resistance’. J. Clin. Pathol. 31: 933 (1978).
J. G. Meingassner, H. Mieth, R. Czok, D.G. Lindmark and M. Müller, Assay conditions and the demonstration of nitro- imidazole resistance to Tritrichomonas foetus. Antimicrob. Agents Chemother. 13: 1 (1978).
E. D. Ralph and D. A. Clarke, Inactivation of metronidazole by anaerobic and aerobic bacteria, Antimicrob. Agents Chemother. 14: 377 (1978).
B. Korner and H. K. Jensen, Sensitivity of Trichomonas vaginalis to metronidazole, tinidazole, and nifuratel in vitro, Brit. J. Vener. Pis. 52: 404 (1976).
G. W. Houghton, P. S. Thorne, J. Smith, R. Templeton and J. Collier, Comparison of the pharmacokinetics of metronidazole in healthy female volunteers following either a single oral or intravenous dose, Br. J. Clin. Pharmac. 8: 337 (1979).
E. D. Ralph and M. M. Kirby, Human pharmacology of oral metronidazole as determined by bioassay, in: “Metronidazole: Proceedings of the International Metronidazole Conference, Montreal, Quebec, Canada”, S. M. Finegold, ed., Excerpta Medica, Amsterdam (1977).
R. Templeton, Metabolism and pharmacokinetics of metronidazoles a review, in “Metronidazole: Proceedings of the International Metronidazole Conference, Montreal, Quebec, Canada”, S.M. Finegold, ed., Excerpta Medica, Amsterdam (1977).
F. D. Gillin and L. S. Diamond, Clonal growth of Entamoeba histolytica in agar, J. Protozool 41: 317 (1980).
L. Jokipii and A. M. Jokipii, In vitro susceptibility of Giardia lamblia trophozoites to metronidazole and tinidazole, J. Infect. Dis. 141: 317 (1980).
H. R. Ingram, S. Eaton, C. W. Venables and P. C. Adams, Bacteroides fragilis resistant to metronidazole after long term therapy, Lancet 1: 214 (1978).
V. O. Rotimi, B. I. Duerden, V. Ede and A. E. MacKinnon, Metronidazole-resistant bacteroides from untreated patient, Lancet 1: 833 (1979).
B. M. Honigberg and M. C. Livingston, In vitro sensitivity of Trichomonas vaginalis to metronidazole, Proc. First Int. Congr. Parasitol. 1: 365 (1966).
A. Čerkasovova and J. Čerkasov, Absence of pyruvate splitting processes in Tritrichomonas foetus resistant to metronidazole, J. Protozool. 25: 34A (1978).
F. P. Tally, D. R. Snydman, M. J. Shimell and B. R. Goldin, Mechanisms of antimicrobial resistance of Bacteroides fragilis, in: “Metronidazole: Royal Society of Medicine International Congress and Symposium Series No.18”, I. Phillips and J. Collier, eds., The Royal Society of Medicine, London (1979).
A. Čerkasovová, J. Čerkasov and J. Kulda, Ethanol formation in the cell of Tritrichomonas foetus, J. Protozool. 26: 39A (1979).
M. Müller, Physiological studies on Trichomonas vaginalis with lowered susceptibility to metronidazole, J. Protozool. 27: 26A (1980).
M. Müller and D. G. Lindmark, Uptake of metronidazole and its effect on viability in trichomonads and Entamoeba invadens under anaerobic and aerobic conditions, Antimicrob. Agents Chemother. 9: 696 (1976).
J. A. McFadzean, I. M. Pugh, S. L. Squires, and J.P.F. Whelan, Further observations on strain sensitivity of Trichomonas vaginalis to metronidazole, Brit. J. Vener. Dis. 45: 161 (1969).
P. I. Edwards, E. J. Thompson, J. Tomusange, and P. Hanson, Inactivation of metronidazole by aerobic organisms, J. Antimicrob. Chemother. 5: 315 (1979).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Press, New York
About this chapter
Cite this chapter
Müller, M. (1982). Resistance to 5-Nitroimidazoles in Pathogenic Microorganisms. In: Breccia, A., Cavalleri, B., Adams, G.E. (eds) Nitroimidazoles. NATO Advanced Study Institutes Series, vol 42. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4151-2_10
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4151-2_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4153-6
Online ISBN: 978-1-4684-4151-2
eBook Packages: Springer Book Archive